Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
8884027
Publication Date
11-11-2014
Abstract
Melampomagnolide B is disclosed as a new antileukemic sesquiterpene. A biotin-conjugated derivative of melampomagnolide B was prepared to elucidate its mechanism of action. Prodrugs of Melampomagnolide B are disclosed.
Assignees
University of Rochester, Rochester, NY (US), University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
13/279,038
Filing Date
10/21/2011
Recommended Citation
Crooks, Peter A.; Jordan, Craig T.; Pei, Shanshan; and Nasim, Shama, "Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents" (2014). Pharmaceutical Sciences Faculty Patents. 25.
https://uknowledge.uky.edu/ps_patents/25
